Two Royal Melbourne Hospital research projects have received Federal Government grants as part of $12 million in funding to support world-class medical research.
Minister for Health, the Hon Greg Hunt, announced the funding, which included grants of more than $300,000 for VIDS Associate Professor Steven Tong and Orygen’s Associate Professor Christopher Davey. Associate Professor Tong, an infectious diseases physician, will use the grant for clinical trials to improve the management of staphylococcal bloodstream infections in Indigenous communities.
Staphylococcal and streptococcal infections can lead to chronic kidney and heart disease and are major causes of illness and death, particularly among Indigenous Australians.
Associate Professor Tong’s research will also seek to understand and reduce the burden of skin infections in Indigenous communities using genomics and mathematical modelling.
Head of Mood Disorders Research at Orygen, Associate Professor Christopher Davey, received funding for his research “Examining new treatments and developing new treatment biomarkers for youth with severe depression.”
While severe depression is often treated with antidepressants and psychotherapy, Associate Professor Davey’s research will investigate new treatment strategies for young people with severe depression and develop better predictors about who is likely to benefit from these treatments.